Sandoz To Build $400 Million Biosimilars Plant in Slovenia
Sandoz To Build $400 Million Biosimilars Plant in Slovenia
GALWAY, IRELAND--March 28, 2023--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--Pharmaceutical company Sandoz has confirmed plans to invest up to US$400 million to build a new biologics production plant in Slovenia, to support increasing global demand for biosimilar medicines.
Within this article: Details Slovenian plant investment, products, timescale, biosimilars market growth
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Novartis To Make Pfizer/BioNTech COVID-19 Vaccine in Slovenia
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
